Sturiale Luisa, Barone Rita, Fiumara Agata, Perez Marta, Zaffanello Marco, Sorge Giovanni, Pavone Lorenzo, Tortorelli Silvia, O'Brien John F, Jaeken Jaak, Garozzo Domenico
Istituto di Chimica e Tecnolgia dei Polimeri, CNA, Viale Regina Margherita 6, I-95123 Catania, Italy.
Glycobiology. 2005 Dec;15(12):1268-76. doi: 10.1093/glycob/cwj021. Epub 2005 Jul 21.
Untreated classic galactosemia (galactose-1-phosphate uridyltransferase [GALT] deficiency) is known as a secondary congenital disorders of glycosylation (CDG) characterized by galactose deficiency of glycoproteins and glycolipids (processing defect or CDG-II). The mechanism of this undergalactosylation has not been established. Here we show that in untreated galactosemia, there is also a partial deficiency of whole glycans of serum transferrin associated with increased fucosylation and branching as seen in genetic glycosylation assembly defects (CDG-I). Thus galactosemia seems to be a secondary "dual" CDG causing a processing as well as an assembly N-glycosylation defect. We also demonstrated that in galactosemia patients, transferrin N-glycan biosynthesis is restored upon dietary treatment.
未经治疗的经典半乳糖血症(1-磷酸半乳糖尿苷转移酶[GALT]缺乏症)是一种继发性先天性糖基化障碍(CDG),其特征是糖蛋白和糖脂的半乳糖缺乏(加工缺陷或CDG-II)。这种半乳糖基化不足的机制尚未明确。我们在此表明,在未经治疗的半乳糖血症中,血清转铁蛋白的全聚糖也存在部分缺乏,同时伴有岩藻糖基化增加和分支增多,这与遗传性糖基化组装缺陷(CDG-I)中所见情况相同。因此,半乳糖血症似乎是一种继发性“双重”CDG,会导致加工以及组装N-糖基化缺陷。我们还证明,在半乳糖血症患者中,饮食治疗后转铁蛋白N-聚糖的生物合成得以恢复。